Phosphorylation, acetylation and ubiquitination: The molecular basis of RUNX regulation

Gene

Volumn 366, Issue 1, 2006, Pages 58-66

  Bae, Suk Chul ^a   Lee, Yong Hee ^a  

^a Chungbuk National University College of Medicine   (South Korea)

Author keywords

Acetylation; Phosphorylation; RUNX; Ubiquitination

Indexed keywords

FIBROBLAST GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PARATHYROID HORMONE; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR RUNX3; TRANSFORMING GROWTH FACTOR BETA;

AUTOIMMUNE DISEASE; BONE DEVELOPMENT; CANCER INHIBITION; CELL DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; CRANIOFACIAL SYNOSTOSIS; HEMATOPOIESIS; HUMAN; LEUKEMIA; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN STABILITY; REGULATORY MECHANISM; REVIEW; SOLID TUMOR; STRUCTURE ACTIVITY RELATION;

ACYLATION; ANIMALS; AUTOIMMUNE DISEASES; BONE DISEASES, DEVELOPMENTAL; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA SUBUNITS; GENE EXPRESSION REGULATION; GENES, TUMOR SUPPRESSOR; HEMATOPOIESIS; HUMANS; NEOPLASMS; NERVE TISSUE; OSTEOGENESIS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; UBIQUITIN;

EID: 32044468546     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2005.10.017     Document Type: Review

References (120)

1. E. Appella, and C.W. Anderson Post-translational modifications and activation of p53 by genotoxic stresses Eur. J. Biochem. 268 2001 2764 2772
2. S.C. Bae, and J.K. Choi Tumor suppressor activity of RUNX3 Oncogene 23 2004 4336 4340
3. N.A. Barlev Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases Mol. Cell 8 2001 1243 1254
4. J. Bravo, Z. Li, N.A. Speck, and A.J. Warren The leukemia-associated AML1 (Runx1)-CBF beta complex functions as a DNA-induced molecular clamp Nat. Struct. Biol. 8 2001 371 378
5. P.C. Brooks, R.L. Klemke, S. Schon, J.M. Lewis, M.A. Schwartz, and D.A. Cheresh Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo J. Clin. Invest. 99 1997 1390 1398
6. L.R. Chase, and G.D. Aurbach The effect of parathyroid hormone on the concentration of adenosine 3′,5′-monophosphate in skeletal tissue in vitro J. Biol. Chem. 245 1970 1520 1526
7. N.H. Chehab, A. Malikzay, M. Appel, and T.D. Halazonetis Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53 Genes Dev. 14 2000 278 288
8. J.A. Cole Parathyroid hormone activates mitogen-activated protein kinase in opossum kidney cells Endocrinology 140 1999 5771 5779
9. D.W. Dempster, F. Cosman, M. Parisien, V. Shen, and R. Lindsay Anabolic actions of parathyroid hormone on bone Endocr. Rev. 14 1993 690 709
10. R. Derynck, R.J. Akhurst, and A. Balmain TGF-beta signaling in tumor suppression and cancer progression Nat. Genet. 29 2001 117 129
11. C. Dhalluin, J.E. Carlson, L. Zeng, C. He, A.K. Aggarwal, and M.M. Zhou Structure and ligand of a histone acetyltransferase bromodomain Nature 399 1999 491 496
12. H. Dobnig, and R.T. Turner Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells Endocrinology 136 1995 3632 3638
13. H. Dobnig, and R.T. Turner The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats Endocrinology 138 1997 4607 4612
14. P. Ducy, R. Zhang, V. Geoffroy, A.L. Ridall, and G. Karsenty Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation Cell 89 1997 747 754
15. M. Fujii Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation Mol. Biol. Cell 10 1999 3801 3813
16. T. Fujita Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling J. Cell Biol. 166 2004 85 95
17. S. Gallea Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells Bone 28 2001 491 498
18. A. Goel Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers Int. J. Cancer 112 2004 754 759
19. H. Hanafusa Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression J. Biol. Chem. 274 1999 27161 27167
20. J. Hanai Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter J. Biol. Chem. 274 1999 31577 31582
21. A.H. Hassan Function and selectivity of bromodomains in anchoring chromatin-modifying complexes to promoter nucleosomes Cell 111 2002 369 379
22. C.H. Heldin, K. Miyazono, and P. ten Dijke TGF-beta signalling from cell membrane to nucleus through SMAD proteins Nature 390 1997 465 471
23. A. Hirao DNA damage-induced activation of p53 by the checkpoint kinase Chk2 Science 287 2000 1824 1827
24. B.L. Hogan Bone morphogenetic proteins: multifunctional regulators of vertebrate development Genes Dev. 10 1996 1580 1594
25. G. Huang, K. Shigesada, K. Ito, H.J. Wee, T. Yokomizo, and Y. Ito Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome- mediated degradation EMBO J. 20 2001 723 733
26. B.P. Hudson, M.A. Martinez-Yamout, H.J. Dyson, and P.E. Wright Solution structure and acetyl-lysine binding activity of the GCN5 bromodomain J. Mol. Biol. 304 2000 355 370
27. Y. Imai The corepressor mSin3A regulates phosphorylation-induced activation, intranuclear location, and stability of AML1 Mol. Cell. Biol. 24 2004 1033 1043
28. K. Inoue Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons Nat. Neurosci. 5 2002 946 954
29. K. Inoue Runx3 is essential for the target-specific axon pathfinding of trkc-expressing dorsal root ganglion neurons Blood Cells Mol. Diseases 30 2003 157 160
30. Y. Ito Molecular basis of tissue-specific gene expression mediated by the runt domain transcription factor PEBP2/CBF Genes Cells 4 1999 685 696
31. Y. Ito Oncogenic potential of the RUNX gene family: 'overview' Oncogene 23 2004 4198 4208
32. Y. Ito, and K. Miyazono RUNX transcription factors as key targets of TGF-beta superfamily signaling Curr. Opin. Genet. Dev. 13 2003 43 47
33. A. Ito p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2 EMBO J. 20 2001 1331 1340
34. E.W. Jabs Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2 Nat. Genet. 8 1994 275 279
35. R.H. Jacobson, A.G. Ladurner, D.S. King, and R. Tjian Structure and function of a human TAFII250 double bromodomain module Science 288 2000 1422 1425
36. J.W. Jeong Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation Cell 111 2002 709 720
37. M.J. Jimenez, M. Balbin, J.M. Lopez, J. Alvarez, T. Komori, and C. Lopez-Otin Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation Mol. Cell. Biol. 19 1999 4431 4442
38. Y.H. Jin Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation J. Biol. Chem. 279 2004 29409 29417
39. G.H. Kang, S. Lee, H.J. Lee, and K.S. Hwang Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia J. Pathol. 202 2004 233 240
40. S. Kang Polymorphism in folate-and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer Gynecol. Oncol. 96 2005 173 180
41. T. Kanno, Y. Kanno, L.F. Chen, E. Ogawa, W.Y. Kim, and Y. Ito Intrinsic transcriptional activation-inhibition domains of the polyomavirus enhancer binding protein 2/core binding factor alpha subunit revealed in the presence of the beta subunit Mol. Cell. Biol. 18 1998 2444 2454
42. Y. Kanno, T. Kanno, C. Sakakura, S.C. Bae, and Y. Ito Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor alpha (CBFalpha) subunit by the leukemia-related PEBP2/CBFbeta-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation Mol. Cell. Biol. 18 1998 4252 4261
43. N. Kato, G. Tamura, M. Fukase, H. Shibuya, and T. Motoyama Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants Am. J. Pathol. 163 2003 387 391
44. H.J. Kim, J.H. Kim, S.C. Bae, J.Y. Choi, H.J. Kim, and H.M. Ryoo The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2 J. Biol. Chem. 278 2003 319 326
45. T.Y. Kim Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma Lab. Invest. 84 2004 479 484
46. I. Kitabayashi, A. Yokoyama, K. Shimizu, and M. Ohki Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation EMBO J. 17 1998 2994 3004
47. T. Komori Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts Cell 89 1997 755 764
48. J.L. Ku Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines Oncogene 23 2004 6736 6742
49. A.G. Ladurner, C. Inouye, R. Jain, and R. Tjian Bromodomains mediate an acetyl-histone encoded antisilencing function at heterochromatin boundaries Mol. Cell 11 2003 365 376
50. B. Lee Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia Nat. Genet. 16 1997 307 310
51. K.S. Lee Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12 Mol. Cell. Biol. 20 2000 8783 8792
52. K.S. Lee, S.H. Hong, and S.C. Bae Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein Oncogene 21 2002 7156 7163
53. D. Levanon, and Y. Groner Structure and regulated expression of mammalian RUNX genes Oncogene 23 2004 4211 4219
54. D. Levanon The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons EMBO J. 21 2002 3454 3463
55. Q.L. Li Causal relationship between the loss of RUNX3 expression and gastric cancer Cell 109 2002 113 124
56. Q.L. Li Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer Biochem. Biophys. Res. Commun. 314 2004 223 228
57. R. Lindsay Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis Lancet 350 1997 550 555
58. A.T. Look Oncogenic transcription factors in the human acute leukemias Science 278 1997 1059 1064
59. W. Lopaczynski Differential regulation of signaling pathways for insulin and insulin-like growth factor I Acta Biochim. Pol. 46 1999 51 60
60. B. Lutterbach, J.J. Westendorf, B. Linggi, S. Isaac, E. Seto, and S.W. Hiebert A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia J. Biol. Chem. 275 2000 651 656
61. J. Massague The transforming growth factor-beta family Annu. Rev. Cell Biol. 6 1990 597 641
62. J. Massague TGF-beta signal transduction Annu. Rev. Biochem. 67 1998 753 791
63. O. Matangkasombut, and S. Buratowski Different sensitivities of bromodomain factors 1 and 2 to histone H4 acetylation Mol. Cell 11 2003 353 363
64. G.A. Meyers, S.J. Orlow, I.R. Munro, K.A. Przylepa, and E.W. Jabs Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans Nat. Genet. 11 1995 462 464
65. K. Miyazono, S. Maeda, and T. Imamura Coordinate regulation of cell growth and differentiation by TGF-beta superfamily and Runx proteins Oncogene 23 2004 4232 4237
66. T. Mori Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma Liver Int. 25 2005 380 388
67. M. Muenke A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome Nat. Genet. 8 1994 269 274
68. S. Mundlos Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia Cell 89 1997 773 779
69. Y. Nakase Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography Br. J. Cancer 92 2005 562 569
70. R. Nishimura, Y. Kato, D. Chen, S.E. Harris, G.R. Mundy, and T. Yoneda Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12 J. Biol. Chem. 273 1998 1872 1879
71. J.C. Obenauer, L.C. Cantley, and M.B. Yaffe Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs Nucleic Acids Res. 31 2003 3635 3641
72. M. Osato Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias Blood 93 1999 1817 1824
73. Y. Oshimo Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma Pathobiology 71 2004 137 143
74. F. Otto Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development Cell 89 1997 765 771
75. D.J. Owen The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase gcn5p EMBO J. 19 2000 6141 6149
76. N.C. Partridge, D. Alcorn, V.P. Michelangeli, B.E. Kemp, G.B. Ryan, and T.J. Martin Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells Endocrinology 108 1981 213 219
77. T. Pawson, and T.M. Saxton Signaling networks-do all roads lead to the same genes? Cell 97 1999 675 678
78. L. Prokunina A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans Nat. Genet. 32 2002 666 669
79. M. Qiao, P. Shapiro, R. Kumar, and A. Passaniti Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway J. Biol. Chem. 279 2004 42709 42718
80. I. Quack Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia Am. J. Hum. Genet. 65 1999 1268 1278
81. C.O. Quinn, D.K. Scott, C.E. Brinckerhoff, L.M. Matrisian, J.J. Jeffrey, and N.C. Partridge Rat collagenase. Cloning, amino acid sequence comparison, and parathyroid hormone regulation in osteoblastic cells J. Biol. Chem. 265 1990 22342 22347
82. W. Reardon, R.M. Winter, P. Rutland, L.J. Pulleyn, B.M. Jones, and S. Malcolm Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome Nat. Genet. 8 1994 98 103
83. A.H. Reddi Bone and cartilage differentiation Curr. Opin. Genet. Dev. 4 1994 737 744
84. C. Sakakura Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer Int. J. Cancer 113 2005 221 228
85. P.C. Schiller, G. D'Ippolito, B.A. Roos, and G.A. Howard Anabolic or catabolic responses of MC3T3-E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment J. Bone Miner. Res. 14 1999 1504 1512
86. K. Schulmann Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk Oncogene 24 2005 4138 4148
87. J.G. Shelton, L.S. Steelman, E.R. White, and J.A. McCubrey Synergy between PI3K/Akt and Raf/MEK/ERK pathways in IGF-1R mediated cell cycle progression and prevention of apoptosis in hematopoietic cells Cell Cycle 3 2004 372 379
88. X. Shen, P.P. Hu, N.T. Liberati, M.B. Datto, J.P. Frederick, and X.F. Wang TGF-beta-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein Mol. Biol. Cell 9 1998 3309 3319
89. S.Y. Shieh, J. Ahn, K. Tamai, Y. Taya, and C. Prives The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites Genes Dev. 14 2000 289 300
90. J. Sierra Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity Mol. Cell. Biol. 23 2003 3339 3351
91. W.J. Song Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia Nat. Genet. 23 1999 166 175
92. E. Soutoglou, N. Katrakili, and I. Talianidis Acetylation regulates transcription factor activity at multiple levels Mol. Cell 5 2000 745 751
93. N.A. Speck, and D.G. Gilliland Core-binding factors in haematopoiesis and leukaemia Nat. Rev. Cancer 2 2002 502 513
94. G.S. Stein Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression Oncogene 23 2004 4315 4329
95. L. Sun, M. Vitolo, and A. Passaniti Runt-related gene 2 in endothelial cells: inducible expression and specific regulation of cell migration and invasion Cancer Res. 61 2001 4994 5001
96. J.T. Swarthout, T.A. Doggett, J.L. Lemker, and N.C. Partridge Stimulation of extracellular signal-regulated kinases and proliferation in rat osteoblastic cells by parathyroid hormone is protein kinase C-dependent J. Biol. Chem. 276 2001 7586 7592
97. G. Tamura Promoter methylation status of tumor suppressor and tumor-related genes in neoplastic and non-neoplastic gastric epithelia Histol. Histopathol. 19 2004 221 228
98. T. Tanaka The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability Mol. Cell. Biol. 16 1996 3967 3979
99. I. Taniuchi Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development Cell 111 2002 621 633
100. K. Thirunavukkarasu, M. Mahajan, K.W. McLarren, S. Stifani, and G. Karsenty Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfbeta Mol. Cell. Biol. 18 1998 4197 4208
101. S. Tokuhiro An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis Nat. Genet. 35 2003 341 348
102. A.J. van Wijnen Nomenclature for Runt-related (RUNX) proteins Oncogene 23 2004 4209 4210
103. M. Wada Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines Oncogene 23 2004 2401 2407
104. H.J. Wee, G. Huang, K. Shigesada, and Y. Ito Serine phosphorylation of RUNX2 with novel potential functions as negative regulatory mechanisms EMBO Rep. 3 2002 967 974
105. J.J. Westendorf Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter Mol. Cell. Biol. 22 2002 7982 7992
106. E. Woolf Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis Proc. Natl. Acad. Sci. U. S. A. 100 2003 7731 7736
107. J.M. Wozney Novel regulators of bone formation: molecular clones and activities Science 242 1988 1528 1534
108. W.H. Xiao, and W.W. Liu Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma World J. Gastroenterol. 10 2004 376 380
109. G. Xiao MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1 J. Biol. Chem. 275 2000 4453 4459
110. G. Xiao, D. Jiang, R. Gopalakrishnan, and R.T. Franceschi Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2 J. Biol. Chem. 277 2002 36181 36187
111. M.B. Yaffe Phosphotyrosine-binding domains in signal transduction Nat. Rev., Mol. Cell Biol. 3 2002 177 186
112. Y. Yamaguchi AML1 is functionally regulated through p300-mediated acetylation on specific lysine residues J. Biol. Chem. 279 2004 15630 15638
113. N. Yamamoto, S. Akiyama, T. Katagiri, M. Namiki, T. Kurokawa, and T. Suda Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts Biochem. Biophys. Res. Commun. 238 1997 574 580
114. N. Yanagawa, G. Tamura, H. Oizumi, N. Takahashi, Y. Shimazaki, and T. Motoyama Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers Cancer Sci. 94 2003 589 592
115. X.J. Yang The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases Nucleic Acids Res. 32 2004 959 976
116. Y. Zhang, and R. Derynck Regulation of Smad signalling by protein associations and signalling crosstalk Trends Cell Biol. 9 1999 274 279
117. Y.W. Zhang A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia Proc. Natl. Acad. Sci. U. S. A. 97 2000 10549 10554
118. Y. Zhang, J.R. Biggs, and A.S. Kraft Phorbol ester treatment of K562 cells regulates the transcriptional activity of AML1c through phosphorylation J. Biol. Chem. 279 2004 53116 53125
119. M. Zhao, M. Qiao, B.O. Oyajobi, G.R. Mundy, and D. Chen E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiation J. Biol. Chem. 278 2003 27939 27944
120. Y.X. Zhou, X. Xu, L. Chen, C. Li, S.G. Brodie, and C.X. Deng A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures Hum. Mol. Genet. 9 2000 2001 2008